<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cenexis Bio | Confidential Briefing [LLNL-02 / CX-101]</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500&family=Plus+Jakarta+Sans:wght@700;800&family=JetBrains+Mono:wght@500&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="style.css">
</head>
<body>

    <div id="preloader">
        <div class="loader-content">
            <h2 class="loader-logo">CENEXIS<span>BIO</span></h2>
            <div class="loader-bar-wrapper"><div class="loader-bar"></div></div>
            <p class="data-label">VERIFYING CNS DEFENSE PROTOCOLS...</p>
        </div>
    </div>

    <nav class="glass-nav">
        <div class="logo">CENEXIS<span>BIO</span></div>
        <ul class="nav-links">
            <li><a href="#gap">The Gap</a></li>
            <li><a href="#solution">Solution</a></li>
            <li><a href="#team">Team</a></li>
            <li><a href="#contact" class="cta-btn">Request Access</a></li>
        </ul>
    </nav>

    <section class="hero">
        <div class="hero-overlay"></div>
        <video autoplay muted loop playsinline class="hero-video">
            <source src="neural-defense.mp4" type="video/mp4">
        </video>
        
        <div class="hero-content">
            <span class="confidential-tag">CONFIDENTIAL BRIEFING // [LLNL-02 / CX-101]</span>
            <h1>BEYOND <span class="outline-text">SURVIVAL.</span></h1>
            <p>Developing the next generation of nerve agent antidotes. The first therapeutic capability designed to preserve both life and brain function.</p>
            <a href="#gap" class="cta-arrow">VIEW THE MISSION ↓</a>
        </div>
    </section>

    <section id="gap" class="services-section">
        <div class="container">
            <div class="section-header">
                <h2 class="section-title">The Status Quo is Grossly Inadequate</h2>
                <p>Nerve agents—including Sarin, VX, and Novichok—remain a credible and evolving threat. Current medical countermeasures were designed for survival, not neuroprotection.</p>
            </div>

            <div class="comparison-grid">
                <div class="glass-card border-red">
                    <h4 class="text-red">BLOOD-BRAIN BARRIER: BLOCKED</h4>
                    <p>Legacy solutions cannot reach the brain effectively to stop central seizure activity.</p>
                </div>
                <div class="glass-card border-green">
                    <h4 class="text-green">TARGET: PENETRATED</h4>
                    <h3 class="text-green">LLNL-02 / CX-101</h3>
                    <p>The first nerve-agent antidote capable of crossing the blood-brain barrier to preserve neurologic function.</p>
                </div>
            </div>

            <blockquote class="modern-quote">
                "Current countermeasures keep the victim alive but leave them unprotected from long-term neurologic injury."
            </blockquote>
        </div>
    </section>

    <section id="status" class="services-section grey-bg">
        <div class="container">
            <h2 class="section-title">De-Risked Execution</h2>
            <div class="stats-grid">
                <div class="stat-item glass-card">
                    <h3>$7M</h3>
                    <p class="data-label">Non-Dilutive Gov Investment</p>
                </div>
                <div class="stat-item glass-card">
                    <h3>LLNL</h3>
                    <p class="data-label">Developed at Lawrence Livermore</p>
                </div>
                <div class="stat-item glass-card">
                    <h3>FDA</h3>
                    <p class="data-label">Animal Rule Pathway</p>
                </div>
                <div class="stat-item glass-card">
                    <h3>US GOV</h3>
                    <p class="data-label">Guaranteed Validator</p>
                </div>
            </div>
        </div>
    </section>

    <section id="team" class="services-section">
        <div class="container">
            <h2 class="section-title">The Architects</h2>
            <div class="team-grid">
                <div class="team-member glass-card">
                    <span class="team-role">CEO</span>
                    <h3>Ray Stevens, MBA</h3>
                    <p>Expertise: Program execution & leadership.</p>
                </div>
                <div class="team-member glass-card">
                    <span class="team-role">CMO</span>
                    <h3>Stewart McCallum, MD FACS</h3>
                    <p>20+ years of global development & regulatory expertise.</p>
                </div>
                <div class="team-member glass-card">
                    <span class="team-role">Head, CMC & Quality</span>
                    <h3>Dale Bennyhoff</h3>
                    <p>25+ years in CMC, scale-up, and GMP readiness.</p>
                </div>
                <div class="team-member glass-card">
                    <span class="team-role">CBO / CFO</span>
                    <h3>Bryan Katz, MBA</h3>
                    <p>26-year pharma leader & US Marine.</p>
                </div>
            </div>
        </div>
    </section>

    <section id="contact" class="footer-section">
        <div class="container">
            <div class="contact-box glass-card text-center">
                <span class="confidential-tag">AUTHORIZED PARTIES ONLY</span>
                <h2>Restricted Access</h2>
                <p>Cenexis Bio is executing a government-aligned Series A roadmap. Detailed data rooms and briefing materials are available upon verified request.</p>
                
                <a href="mailto:info@cenexisbio.com?subject=Briefing Request: Authorized Access" class="btn-request-large">REQUEST BRIEFING ACCESS</a>
            </div>
            
            <div class="contact-links">
                <p class="data-label">Direct Executive Outreach:</p>
                <div class="link-group">
                    <a href="mailto:info@cenexisbio.com">Ray Stevens (CEO)</a>
                    <span class="divider">|</span>
                    <a href="mailto:info@cenexisbio.com">Bryan Katz (CBO)</a>
                </div>
            </div>
            <p class="copyright">© 2026 Cenexis Bio. All Rights Reserved.</p>
        </div>
    </section>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/gsap/3.12.2/gsap.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/gsap/3.12.2/ScrollTrigger.min.js"></script>
    <script>
        window.addEventListener('load', () => {
            gsap.registerPlugin(ScrollTrigger);
            gsap.set("body", { visibility: "visible" });

            const tl = gsap.timeline();
            tl.to(".loader-bar", { width: "100%", duration: 1.5 })
              .to("#preloader", { yPercent: -100, duration: 1.2, ease: "expo.inOut" })
              .from(".hero-content *", { opacity: 0, y: 30, stagger: 0.2, duration: 1 });

            // Animate sections into view
            gsap.utils.toArray(".services-section").forEach(section => {
                gsap.from(section.querySelectorAll(".glass-card"), {
                    scrollTrigger: {
                        trigger: section,
                        start: "top 80%"
                    },
                    opacity: 0,
                    y: 40,
                    stagger: 0.15,
                    duration: 0.8,
                    ease: "power2.out"
                });
            });
        });
    </script>
</body>
</html>
